National Pharmacovigilance Programme: First National Consultative meeting of the National Pharmacovigilance Programme for ASU Drugs was held at the Dept. of AYUSH, Ministry of Health & FW, and New Delhi on August 2008, supported by WHO. After that, National Pharmacovigilance Programme for ASU drugs was launched on 29th Sept 2008. The purpose of the program is to collect, collate, and analyze data to use the inferences to recommend informed regulatory interventions, besides communicating risks to healthcare professionals and the public. The National Institute of Unani Medicine, Bengaluru, is the National Pharmacovigilance Resource Centre for Ayurveda, Siddha, and Unani Drugs (NPRC-ASU) in India under the Central sector scheme for upgradation to Centre of Excellence since 2008-09. Under NPRC-ASU drugs, there are five Intermediary Pharmacovigilance Centres (IPvC) for ASU drugs. There are 74 Peripheral Pharmacovigilance Centres (PPvC) for ASU drugs, which are working under these Four IPvCs, across the country. Adverse drug reactions related to any ASU drugs are being reported to these PPvC, in a specially designed ADR reporting form. The program is intended to collect, collate and analyze data to establish evidence for the clinical safety of ASU & H drugs scientifically for documenting clinical evidence of safety and to undertake surveillance of misleading advertisements of ASU & H drugs and improper advertisements of ASU & H drugs for regulatory actions. Pharmacovigilance is dedicated to reducing the risk of drug-related harm to consumers.

1. National Pharmacovigilance Programme
forASU Drugs
DR. MD. KHURSID ALAM
PRESIDENT
ASSOCIATION OF UNANI PHYSICIANS, BIHAR

2. National Pharmacovigilance Programme
First National Consultative meeting of the National
Pharmacovigilance Programme for ASU Drugs was held at
the Dept. of AYUSH, Ministry of Health & FW, and New
Delhi on August 2008, supported by WHO. After that,
National Pharmacovigilance Programme for ASU drugs was
launched on 29th Sept 2008.

3. Pharmacovigilance Programme

4. Purpose of the program
The purpose of the program is to collect, collate, and
analyze data to use the inferences to recommend
informed regulatory interventions, besides
communicating risks to healthcare professionals and the
public.

6. Pharmacovigilance Centres Across Country
The National Institute of Unani Medicine, Bengaluru, is the
National Pharmacovigilance Resource Centre for Ayurveda,
Siddha, and Unani Drugs (NPRC-ASU) in India under the
Central sector scheme for upgradation to Centre of Excellence
since 2008-09. Under NPRC-ASU drugs, there are five
Intermediary Pharmacovigilance Centres (IPvC) for ASU drugs.
There are 74 Peripheral Pharmacovigilance Centres (PPvC) for
ASU drugs, which are working under these Four IPvCs, across
the country.

7. ADR Reporting

8. Documention of ADR Data
Adverse drug reactions related to any ASU drugs are being
reported to these PPvC, in a specially designed ADR reporting
form. The program is intended to collect, collate and analyze data
to establish evidence for the clinical safety of ASU & H drugs
scientifically for documenting clinical evidence of safety and to
undertake surveillance of misleading advertisements of ASU & H
drugs and improper advertisements of ASU & H drugs for
regulatory actions. Pharmacovigilance is dedicated to reducing
the risk of drug-related harm to consumers.

9. Unani Drugs
Thank You